Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -666037.76% is 141% below its 1-year average of -276088.58%, around the middle of its 1-year range (-966683.10%–0.00%).
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-666037.76%
NET PROFIT MARGIN AVG TTM
N/A
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-256168269.23%
vs the sector median at left
Caring Brands, Inc.
Market Cap
$11.36M
Net Profit Margin
-666037.76%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.55M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.12M
Net Profit Margin
-2702.64%
TTM Avg
-8035.59%
3Y Avg
1817.42%
5Y Avg
219.40%
Market Cap
$11.08M
Net Profit Margin
0.00%
TTM Avg
11.23%
3Y Avg
5.62%
5Y Avg
-9479.86%
Market Cap
$11.02M
Net Profit Margin
-14621.00%
TTM Avg
-5877.48%
3Y Avg
-2938.74%
5Y Avg
-1959.16%
Market Cap
$11.00M
Net Profit Margin
N/A
TTM Avg
-2424.09%
3Y Avg
-1624.47%
5Y Avg
-1082.98%
Market Cap
$11.77M
Net Profit Margin
-6.88%
TTM Avg
-8.42%
3Y Avg
-15.06%
5Y Avg
-13.62%
Market Cap
$10.94M
Net Profit Margin
-620.70%
TTM Avg
-326.13%
3Y Avg
-2493.66%
5Y Avg
-2115.74%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caring Brands, Inc. (CABR) | $11.36M | -666037.76% | N/A | N/A | N/A |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.12M | -2702.64% | -8035.59% | 1817.42% | 219.40% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.08M | 0.00% | 11.23% | 5.62% | -9479.86% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.02M | -14621.00% | -5877.48% | -2938.74% | -1959.16% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.00M | N/A | -2424.09% | -1624.47% | -1082.98% |
| IRIDEX Corporation (IRIX)vs › | $11.77M | -6.88% | -8.42% | -15.06% | -13.62% |
| Cerenome, Inc. (CNSY)vs › | $10.94M | -620.70% | -326.13% | -2493.66% | -2115.74% |
| BioVie Inc. (BIVI)vs › | $10.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Polyrizon Ltd. (PLRZ)vs › | $10.83M | N/A | 0.00% | 0.00% | 0.00% |
Operating Margin
-140807.2%
Net Profit Margin
-666037.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | -966683.10% |
| 2025-09-30 | -137671.22% |
